
Trade in the amphetamine-type stimulant captagon in the Middle East grew exponentially in 2021 to top $5 billion, posing an increasing health and security risk to the region, a report said.
Research by the New Lines Institute, seen by AFP, paints an alarming picture of the impact booming captagon production is having on the region.